{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:50:06Z","timestamp":1788349806289,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1245\/s10434-014-4208-2","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T17:48:35Z","timestamp":1415036915000},"page":"2700-2706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer"],"prefix":"10.1245","volume":"22","author":[{"given":"Allen S.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnbjorn","family":"Toset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Michael","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ganly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"4208_CR1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-142-11-200506070-00011","volume":"142","author":"MR Castro","year":"2005","unstructured":"Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med. 2005;142:926-31.","journal-title":"Ann Intern Med."},{"key":"4208_CR2","doi-asserted-by":"crossref","unstructured":"American Thyroid Association Guidelines Task Force1, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19(6):565\u2013612.","DOI":"10.1089\/thy.2008.0403"},{"key":"4208_CR3","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","volume":"107","author":"S Roman","year":"2006","unstructured":"Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107:2134-42.","journal-title":"Cancer."},{"key":"4208_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.6004\/jnccn.2010.0040","volume":"8","author":"RM Tuttle","year":"2010","unstructured":"Tuttle RM, Ball DW, Byrd D, et al. Medullary carcinoma. J Natl Compr Cancer Netw. 2010;8:512-30.","journal-title":"J Natl Compr Cancer Netw."},{"key":"4208_CR5","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1556::AID-CNCR20>3.0.CO;2-Y","volume":"77","author":"ME Dottorini","year":"1996","unstructured":"Dottorini ME, Assi A, Sironi M, et al. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 1996;77:1556-65.","journal-title":"Cancer"},{"key":"4208_CR6","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2173::AID-CNCR20>3.0.CO;2-V","volume":"78","author":"L Scopsi","year":"1996","unstructured":"Scopsi L, Sampietro G, Boracchi P, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients. Cancer. 1996;78:2173-83.","journal-title":"Cancer."},{"key":"4208_CR7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00268-007-9317-7","volume":"32","author":"E Fialkowski","year":"2008","unstructured":"Fialkowski E, DeBenedetti M, Moley J. Long-term outcome of reoperations for medullary thyroid carcinoma. World J Surg. 2008;32:754-65.","journal-title":"World J Surg."},{"key":"4208_CR8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00268-004-7608-9","volume":"28","author":"J Ukkat","year":"2004","unstructured":"Ukkat J, Gimm O, Brauckhoff M, et al. Single center experience in primary surgery for medullary thyroid carcinoma. World J Surg. 2004;28:1271-4.","journal-title":"World J Surg."},{"key":"4208_CR9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1067\/msy.2001.118380a","volume":"130","author":"T Weber","year":"2001","unstructured":"Weber T, Schilling T, Frank-Raue K, et al. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery. 2001;130:1044-9.","journal-title":"Surgery."},{"key":"4208_CR10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/SLA.0b013e31813e66b9","volume":"246","author":"K Cupisti","year":"2007","unstructured":"Cupisti K, Wolf A, Raffel A, et al. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution\u2019s experience over 20 years. Ann Surg. 2007;246:815-21.","journal-title":"Ann Surg."},{"key":"4208_CR11","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364-70.","journal-title":"J Clin Oncol."},{"key":"4208_CR12","unstructured":"Memorial Sloan-Kettering Cancer Center. Prediction tools. http:\/\/www.mskcc.org\/cancer-care\/prediction-tools , 2013."},{"key":"4208_CR13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1245\/ASO.2005.06.037","volume":"12","author":"MC Specht","year":"2005","unstructured":"Specht MC, Kattan MW, Gonen M, et al. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol. 2005;12:654-9.","journal-title":"Ann Surg Oncol."},{"key":"4208_CR14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/suro.2002.32490","volume":"20","author":"PL Ross","year":"2002","unstructured":"Ross PL, Gerigk C, Gonen M, et al. Comparisons of nomograms and urologists\u2019 predictions in prostate cancer. Semin Urol Oncol. 2002;20:82-8.","journal-title":"Semin Urol Oncol."},{"key":"4208_CR15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.6004\/jnccn.2010.0016","volume":"8","author":"MH Kawachi","year":"2010","unstructured":"Kawachi MH, Bahnson RR, Barry M, et al: NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Cancer Netw. 2010;8:240-62.","journal-title":"J Natl Compr Cancer Netw."},{"key":"4208_CR16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471-4.","journal-title":"Ann Surg Oncol."},{"key":"4208_CR17","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/0026-0495(71)90037-0","volume":"20","author":"LJ Deftos","year":"1971","unstructured":"Deftos LJ: Immunoassay for human calcitonin. I. Method. Metabolism. 1971;20:1122-8.","journal-title":"Metabolism."},{"key":"4208_CR18","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1210\/jc.2005-0044","volume":"90","author":"J Barbet","year":"2005","unstructured":"Barbet J, Campion L, Kraeber-Bodere F, et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2005;90:6077-84.","journal-title":"J Clin Endocrinol Metab."},{"key":"4208_CR19","doi-asserted-by":"crossref","first-page":"e20353","DOI":"10.1371\/journal.pone.0020353","volume":"6","author":"XP Qi","year":"2011","unstructured":"Qi XP, Ma JM, Du ZF, et al. RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A\/familial medullary thyroid carcinoma family. PLoS One. 2011;6:e20353.","journal-title":"PLoS One."},{"key":"4208_CR20","doi-asserted-by":"crossref","unstructured":"Agrawal N, Jiao Y, Sausen M, et al. Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. J Clin Endocrinol Metab. 2013;98(2):364\u2013369.","DOI":"10.1210\/jc.2012-2703"},{"key":"4208_CR21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2265.2009.03666.x","volume":"72","author":"JA Meijer","year":"2010","unstructured":"Meijer JA, le Cessie S, van den Hout WB, et al. Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis. Clin Endocrinol (Oxf). 2010;72:534-42.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"4208_CR22","first-page":"267","volume":"25","author":"R Bellantone","year":"2000","unstructured":"Bellantone R, Boscherini M, Lombardi CP, et al. Medullary thyroid carcinoma: surgical management of primary tumor and locoregional recurrence. Rays. 2000;25:267-71.","journal-title":"Rays."},{"key":"4208_CR23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-07-0667","volume":"158","author":"A Laure Giraudet","year":"2008","unstructured":"Laure Giraudet A, Al Ghulzan A, Auperin A, et al. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol. 2008;158:239-46.","journal-title":"Eur J Endocrinol."},{"key":"4208_CR24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/thy.2007.0413","volume":"18","author":"TS Wang","year":"2008","unstructured":"Wang TS, Ocal IT, Sosa JA, et al. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. Thyroid. 2008;18:889-94.","journal-title":"Thyroid."},{"key":"4208_CR25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/thy.2007.0231","volume":"18","author":"JM Dora","year":"2008","unstructured":"Dora JM, Canalli MH, Capp C, et al. Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature. Thyroid. 2008;18:895-9.","journal-title":"Thyroid."},{"key":"4208_CR26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/1097-0142(19840115)53:2<278::AID-CNCR2820530216>3.0.CO;2-Z","volume":"53","author":"B Busnardo","year":"1984","unstructured":"Busnardo B, Girelli ME, Simioni N, et al. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma. Cancer. 1984;53:278-85.","journal-title":"Cancer."},{"key":"4208_CR27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.bjc.6600930","volume":"88","author":"G Pellegriti","year":"2003","unstructured":"Pellegriti G, Leboulleux S, Baudin E, et al. Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging. Br J Cancer. 2003;88:1537-42.","journal-title":"Br J Cancer."},{"key":"4208_CR28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00268-008-9795-2","volume":"33","author":"Y Ito","year":"2009","unstructured":"Ito Y, Miyauchi A, Yabuta T, et al. Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World J Surg. 2009;33:58-66.","journal-title":"World J Surg."},{"key":"4208_CR29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","volume":"48","author":"E Modigliani","year":"1998","unstructured":"Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d\u2019etude des tumeurs a calcitonine. Clin Endocrinol (Oxf). 1998;48:265-73.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"4208_CR30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ncpuro0968","volume":"4","author":"MW Kattan","year":"2007","unstructured":"Kattan MW, Scardino PT. Evidence for the usefulness of nomograms. Nat Clin Pract Urol. 2007;4:638-9.","journal-title":"Nat Clin Pract Urol."},{"key":"4208_CR31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1200\/JCO.2007.14.1291","volume":"26","author":"MR Weiser","year":"2008","unstructured":"Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008;26:380-5.","journal-title":"J Clin Oncol."},{"key":"4208_CR32","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","volume":"23","author":"AJ Stephenson","year":"2005","unstructured":"Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005;23:7005-12.","journal-title":"J Clin Oncol."},{"key":"4208_CR33","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","volume":"28","author":"U Rudloff","year":"2010","unstructured":"Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28:3762-9.","journal-title":"J Clin Oncol."},{"key":"4208_CR34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.sla.0000133125.85489.07","volume":"240","author":"MF Brennan","year":"2004","unstructured":"Brennan MF, Kattan MW, Klimstra D, et al. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240:293-8.","journal-title":"Ann Surg."},{"key":"4208_CR35","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1200\/JCO.2005.05.3884","volume":"24","author":"BH Bochner","year":"2006","unstructured":"International Bladder Cancer Nomogram C, Bochner BH, Kattan MW, et al. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24:3967-72.","journal-title":"J Clin Oncol."},{"key":"4208_CR36","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2006.10.3820","volume":"25","author":"J Walz","year":"2007","unstructured":"Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol. 2007;25:3576-81.","journal-title":"J Clin Oncol."},{"key":"4208_CR37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1245\/ASO.2006.03.078","volume":"13","author":"LA Lambert","year":"2006","unstructured":"Lambert LA, Ayers GD, Hwang RF, et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol. 2006;13:310-20.","journal-title":"Ann Surg Oncol."},{"key":"4208_CR38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.juro.2006.08.068","volume":"177","author":"EW Steyerberg","year":"2007","unstructured":"Steyerberg EW, Roobol MJ, Kattan MW, et al. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 2007;177:107-12; discussion 112.","journal-title":"J Urol"},{"key":"4208_CR39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eururo.2011.07.066","volume":"61","author":"P Nuhn","year":"2012","unstructured":"Nuhn P, May M, Sun M, et al. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. Eur Urol 2012;61:58-64.","journal-title":"Eur Urol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4208-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4208-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4208-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:16Z","timestamp":1566000016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4208-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["4208"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4208-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,4]]}}}